Home
>
National Drug Code (NDC)
>
Senexon
Senexon - 0536-1275-59 - (Standardized Senna Concentrate)
Drug Information of Senexon
| Product NDC: | 0536-1275 |
| Proprietary Name: | Senexon |
| Non Proprietary Name: | Standardized Senna Concentrate |
| Active Ingredient(s): | 8.8 mg/5mL & nbsp; Standardized Senna Concentrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Senexon
| Product NDC: | 0536-1275 |
| Labeler Name: | Rugby Laboratories |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part334 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20121023 |
Package Information of Senexon
| Package NDC: | 0536-1275-59 |
| Package Description: | 237 mL in 1 BOTTLE, PLASTIC (0536-1275-59) |
NDC Information of Senexon
| NDC Code | 0536-1275-59 |
| Proprietary Name | Senexon |
| Package Description | 237 mL in 1 BOTTLE, PLASTIC (0536-1275-59) |
| Product NDC | 0536-1275 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Standardized Senna Concentrate |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20121023 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Rugby Laboratories |
| Substance Name | SENNOSIDES |
| Strength Number | 8.8 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes |
